BORGIA, GUGLIELMO
 Distribuzione geografica
Continente #
AS - Asia 6.287
NA - Nord America 5.814
EU - Europa 4.927
SA - Sud America 821
AF - Africa 185
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.048
Nazione #
US - Stati Uniti d'America 5.470
SG - Singapore 3.628
RU - Federazione Russa 2.661
CN - Cina 1.354
IT - Italia 703
BR - Brasile 686
HK - Hong Kong 554
VN - Vietnam 395
NL - Olanda 311
FI - Finlandia 263
DE - Germania 243
CA - Canada 225
IE - Irlanda 173
GB - Regno Unito 150
UA - Ucraina 120
MX - Messico 84
IN - India 76
SE - Svezia 68
AR - Argentina 65
ZA - Sudafrica 63
PL - Polonia 54
BD - Bangladesh 51
CI - Costa d'Avorio 49
FR - Francia 42
TR - Turchia 34
ES - Italia 32
JP - Giappone 30
IQ - Iraq 24
AT - Austria 23
LT - Lituania 21
ID - Indonesia 19
UZ - Uzbekistan 18
EC - Ecuador 16
EG - Egitto 14
VE - Venezuela 14
PK - Pakistan 13
TN - Tunisia 13
KR - Corea 12
CZ - Repubblica Ceca 11
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
UY - Uruguay 9
MA - Marocco 8
SA - Arabia Saudita 8
BE - Belgio 7
CO - Colombia 7
AZ - Azerbaigian 6
CL - Cile 6
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
RS - Serbia 6
SV - El Salvador 6
AF - Afghanistan, Repubblica islamica di 5
BG - Bulgaria 5
IR - Iran 5
KZ - Kazakistan 5
AO - Angola 4
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
GT - Guatemala 4
JM - Giamaica 4
PE - Perù 4
AL - Albania 3
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
LU - Lussemburgo 3
MN - Mongolia 3
PH - Filippine 3
PR - Porto Rico 3
RO - Romania 3
SN - Senegal 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BZ - Belize 2
CU - Cuba 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GE - Georgia 2
HT - Haiti 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
SD - Sudan 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AD - Andorra 1
BB - Barbados 1
Totale 18.011
Città #
Singapore 1.686
Chandler 606
Moscow 586
Hong Kong 553
Ashburn 469
Beijing 413
Santa Clara 336
Amsterdam 290
Millbury 282
Los Angeles 214
Princeton 198
Nanjing 188
Naples 176
San Jose 163
Ottawa 138
Ho Chi Minh City 134
Jacksonville 116
New York 115
Boston 104
Napoli 104
Munich 94
Hanoi 93
Des Moines 85
Hefei 84
The Dalles 83
São Paulo 79
Redondo Beach 73
Buffalo 70
Wilmington 70
Nanchang 64
Boardman 51
Warsaw 51
Dallas 47
Mexico City 42
Seattle 41
Turku 41
Brooklyn 40
Hebei 40
Houston 40
Montreal 39
Jiaxing 38
Chicago 36
Denver 36
Orem 35
Poplar 34
Shenyang 34
Ann Arbor 33
Helsinki 33
Tianjin 31
Woodbridge 31
Johannesburg 30
Tokyo 30
Lawrence 28
Chennai 27
Stockholm 26
Atlanta 25
Nuremberg 25
London 24
Norwalk 21
Phoenix 20
San Francisco 20
Toronto 20
Changsha 19
Falkenstein 19
Querétaro 19
Ninh Bình 18
Belo Horizonte 16
Da Nang 16
Ankara 15
Frankfurt am Main 15
Tashkent 15
Indiana 14
Porto Alegre 14
Rio de Janeiro 13
Haiphong 12
Shanghai 12
Curitiba 11
Dublin 11
Falls Church 11
Hangzhou 11
Manchester 11
Rome 11
Salvador 11
Seoul 11
Calgary 10
Campinas 10
Caserta 10
Dhaka 10
Guangzhou 10
Milan 10
Secaucus 10
Brasília 9
Florence 9
Biên Hòa 8
Cairo 8
Hải Dương 8
Pomigliano D'arco 8
Quito 8
Zhengzhou 8
Boise 7
Totale 9.183
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 158
Febbre di origine sconosciuta (FUO): nostra casistica 148
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 141
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 137
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 136
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 132
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 131
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 128
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 127
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 126
HIV and hepatitis C virus: facts and controversies 123
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 123
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 123
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 122
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 121
Asunaprevir for hepatitis C: A safety evaluation 121
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 119
Does compulsory vaccination limit personal freedom? Ethical issues 119
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 118
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 118
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 116
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 116
[Intranuclear particles in chronic non-A, non-B hepatitis: what diagnostic significance?]. 114
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 114
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 112
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 111
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 110
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 109
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 109
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 109
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 107
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 107
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 107
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 107
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 107
Human immunodeficiency virus per se exerts atherogenic effects. 106
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 105
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 105
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 104
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 104
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 104
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 104
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 103
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 103
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 103
Beclabuvir for the treatment of hepatitis C 103
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 103
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 103
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 102
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 102
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 102
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 101
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 101
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 101
Current evidence on the management of hepatitis B in pregnancy 100
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 100
Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review 100
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 100
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 100
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 99
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 99
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE 98
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 96
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 96
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. 95
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 95
Tenofovir and its potential in the treatment of hepatitis B virus 95
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 95
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 95
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 94
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 94
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 94
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review 94
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 94
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 93
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 93
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 93
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 93
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 92
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 92
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis 91
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 91
POEMS syndrome: clinical, pathological and immunological study of a case 90
Compromissione cognitiva subclinica in pazienti HCV-positivi 90
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma 90
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 90
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 90
Specific immunoglobulin against HCV: new perspectives. 89
Mutante lamivudino-resistente in paziente in profilassi con lamivudina in corso di chemioterapia antiblastica per linfoma non-Hodgkin: recupero clinico con terapia di associazione lamivudina e adefovir. 89
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 89
Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients. 88
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 88
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 88
Diffusione dell'infezione da virus epatitico B in ambiente odontoiatrico 87
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. 87
Efficacy and Safety of Sofosbuvir in Treatment of Chronic Hepatitis C: The Dawn of the a New Era. 87
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. 87
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 87
A RARE CASE OF BRAINSTEM ENCEPHALITIS BY LISTERIA MONOCYTOGENES WITH ISOLATED MESENCEPHALIC LOCALIZATION. CASE REPORT AND REVIEW. 86
[Hematologic alterations induced by contrast media]. 86
Totale 10.444
Categoria #
all - tutte 63.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021131 0 0 0 0 0 0 30 3 36 18 32 12
2021/20221.113 5 3 0 6 4 31 5 38 176 79 210 556
2022/20231.574 234 86 24 135 162 182 2 134 250 285 51 29
2023/2024923 34 156 216 36 31 58 19 81 9 16 164 103
2024/20255.840 328 381 13 94 142 257 554 325 503 597 2.084 562
2025/20266.840 1.209 589 1.025 1.138 2.085 590 204 0 0 0 0 0
Totale 18.340